Management of blood pressure in heart failure

被引:41
作者
Pinho-Gomes, Ana Catarina [1 ,2 ]
Rahimi, Kazem [1 ,2 ]
机构
[1] Univ Oxford, George Inst Global Hlth, Oxford OX1 2JD, England
[2] Univ Oxford, Oxford Martin Sch, Deep Med, Oxford, England
关键词
VENTRICULAR EJECTION FRACTION; PULSE-WAVE VELOCITY; MORTALITY; MORBIDITY; OUTCOMES; PROGNOSIS; EFFICACY; INSIGHTS; BLOCKER; IMPACT;
D O I
10.1136/heartjnl-2018-314438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is a common comorbidity in patients with heart failure and most drugs that have demonstrated to improve prognosis in this population have the potential to reduce blood pressure. Nonetheless, the relationship between blood pressure and clinical outcomes and the relevance of blood pressure reduction in heart failure remains unclear. This narrative review summarises the evidence currently available to guide blood pressure treatment in this patient group and highlights key questions for further research. In patients with heart failure with reduced ejection fraction, guidelines consensually recommend treating hypertension with drugs that have compelling indications in heart failure, with a target blood pressure of 130/80 mmHg. In patients with heart failure with preserved ejection fraction, guidelines acknowledge that the optimal treatment strategy remains unclear and thus recommend adopting a similar treatment strategy to patients with reduced ejection fraction. In any case, low blood pressure should not deter uptitration of drugs otherwise indicated to improve prognosis in heart failure, provided that patients tolerate drugs without adverse events. In the absence of evidence for modification of treatment efficacy and safety by baseline blood pressure, it is likely that treatment may actually lead to higher absolute risk reduction in patients with the lowest blood pressure. Special considerations and treatment adjustments are needed in the elderly as well as in patients with diabetes, chronic kidney disease and atrial fibrillation. More evidence is needed on blood pressure management in patients with heart failure in general, in whom the increasing burden of multimorbidity adds further complexity to treatment.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 30 条
  • [11] Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
    Gakidou, Emmanuela
    Afshin, Ashkan
    Abajobir, Amanuel Alemu
    Abate, Kalkidan Hassen
    Abbafati, Cristiana
    Abbas, Kaja M.
    Abd-Allah, Foad
    Abdulle, Abdishakur M.
    Abera, Semaw Ferede
    Aboyans, Victor
    Abu-Raddad, Laith J.
    Abu-Rmeileh, Niveen M. E.
    Abyu, Gebre Yitayih
    Adedeji, Isaac Akinkunmi
    Adetokunboh, Olatunji
    Afarideh, Mohsen
    Agrawal, Anurag
    Agrawal, Sutapa
    Kiadaliri, Aliasghar Ahmad
    Ahmadieh, Hamid
    Ahmed, Muktar Beshir
    Aichour, Amani Nidhal
    Aichour, Ibtihel
    Aichour, Miloud Taki Eddine
    Akinyemi, Rufus Olusola
    Akseer, Nadia
    Alahdab, Fares
    Al-Aly, Ziyad
    Alam, Khurshid
    Alam, Noore
    Alam, Tahiya
    Alasfoor, Deena
    Alene, Kefyalew Addis
    Ali, Komal
    Alizadeh-Navaei, Reza
    Alkerwi, Ala'a
    Alla, Francois
    Allebeck, Peter
    Al-Raddadi, Rajaa
    Alsharif, Ubai
    Altirkawi, Khalid A.
    Alvis-Guzman, Nelson
    Amare, Azmeraw T.
    Amini, Erfan
    Ammar, Walid
    Amoako, Yaw Ampem
    Ansari, Hossein
    Anto, Josep M.
    Antonio, Carl Abelardo T.
    Anwari, Palwasha
    [J]. LANCET, 2017, 390 (10100) : 1345 - 1422
  • [12] Hjalmarson Å, 1999, LANCET, V353, P2001
  • [13] Relation of Left Ventricular Ejection Fraction and Clinical Features or Co-morbidities to Outcomes Among Patients Hospitalized for Acute Heart Failure Syndromes
    Kajimoto, Katsuya
    Sato, Naoki
    Takano, Teruo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (03) : 334 - 340
  • [14] Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
    Law, MR
    Wald, NJ
    Morris, JK
    Jordan, RE
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7404): : 1427 - 1431
  • [15] Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure - The MACH-1 study
    Levine, TB
    Bernink, PJLM
    Caspi, A
    Elkayam, U
    Geltman, EM
    Greenberg, B
    McKenna, WJ
    Ghali, JK
    Giles, TD
    Marmor, A
    Reisin, LH
    Ammon, S
    Lindberg, E
    [J]. CIRCULATION, 2000, 101 (07) : 758 - 764
  • [16] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
  • [17] Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
    Lip, Gregory Y. H.
    Skjoth, Flemming
    Overvad, Kim
    Rasmussen, Lars Hvilsted
    Larsen, Torben Bjerregaard
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (12) : 1088 - 1096
  • [18] Elevated Arterial Stiffness Evaluated by Brachial-Ankle Pulse Wave Velocity is Deleterious for the Prognosis of Patients With Heart Failure
    Meguro, Tomomi
    Nagatomo, Yuji
    Nagae, Atsushi
    Seki, Chiori
    Kondu, Nobusuke
    Shibata, Masaru
    Oda, Yutaka
    [J]. CIRCULATION JOURNAL, 2009, 73 (04) : 673 - 680
  • [19] Messerli Franz H, 2017, JACC Heart Fail, V5, P543, DOI 10.1016/j.jchf.2017.04.012
  • [20] Nichols GA, 2015, AM J CARDIOL, V116, P1088, DOI [10.1016/j.amjcard.2015.07.018, 10.5935/2359-4802.20160060]